Erratum to: PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy
Breast Cancer Res Treat. 2016 Apr;156(2):405-6.
doi: 10.1007/s10549-016-3752-9.
1 Braman Family Breast Cancer Institute at Sylvester, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA.
2 S. and D. Fuente Graduate Program in Cancer Biology, Miami, FL, 33136, USA.
3 Department of Medicine, U of Miami Miller School of Medicine, Miami, FL, 33136, USA.
4 Department of Pathology, University of Miami, Miami, FL, 33136, USA.
5 Department of Radiation Oncology, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
6 Division of Biostatistics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
7 Braman Family Breast Cancer Institute at Sylvester, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA. jslingerland@med.miami.edu.
8 Department of Medicine, U of Miami Miller School of Medicine, Miami, FL, 33136, USA. jslingerland@med.miami.edu.
9 Department of Biochemistry & Molecular Biology, University of Miami, Miami, FL, 33136, USA. jslingerland@med.miami.edu.
Erratum to: Breast Cancer Res Treat (2013),138:369–381,DOI 10.1007/s10549-012-2389-6. In the original publication of the article, the Fig. 4c and d were published erroneously. The revised Fig. 4 is given in this erratum.